Elevance Health Inc. (ELV)
Last Price$541.76(0.0%)
Market Cap$128.0bn
Financial profile score
5/10
LTM Revenue
$171.7 bn
0.0% YoY
LTM Net Income
$6.7 bn
+7.2% YoY
LTM Free Cash Flow
$0.8 bn
-64.3% YoY
Net Debt
$21.2 bn
Short-term financial position
2.2x
Current Assets / Current Liabilities
ELV Income statement
Crunching data... Almost there!
Earnings growth (>10% annually)
ELV's earnings have grown by 4.6% per year over the past 5 years.
Growing Net income margin
ELV's net income margin has decreased (-0.3%)
in the last year from (3.8%) to (3.5%)
ELV Balance sheet
Crunching data... Almost there!
ELV Key balance sheet metrics
Crunching data... Almost there!
ELV Cash flow statement
Crunching data... Almost there!
ELV Key cash flow statement metrics
Crunching data... Almost there!
Growing free cash flow margin
ELV's free cash flow margin has decreased
(-0.7%)
in the last year from (4.6%) to (3.9%)
Discover more ELV fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What are Elevance Health Inc. (ELV) Key Income Statement Metrics?
As of today, Elevance Health Inc. last 12-month Revenue is $171.7 bn , EBITDA is $36.4 bn and Net Income is $6.7 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are Elevance Health Inc. (ELV) Key Balance Sheet Metrics?
As of today, Elevance Health Inc. Total Assets are $142.5 bn and Total Liabilities are $70.7 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are Elevance Health Inc. (ELV) Key Cash Flow Statement Metrics?
As of today, Elevance Health Inc. last 12-month Cash Flow from Operating Activities is $0.4 bn, Cash Flow from Investing Activities is $-0.8 bn and Cash Flow from Financing Activities is $0.7 bn, based on the financial report for June 30, 2024 (Q2 2024).
What is Elevance Health Inc. (ELV) Free Cash Flow?
As of today, Elevance Health Inc. last 12-month Free Cash Flow is $0.8 bn , based on the financial report for June 30, 2024 (Q2 2024).